This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kshatriya, R.
Right arrow Articles by Fiscus, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kshatriya, R.
Right arrow Articles by Fiscus, S. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2008, p. 3482-3483, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.00665-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Comparison of Two Rapid Human Immunodeficiency Virus (HIV) Assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for Detection of Recent HIV Seroconversion{triangledown}

Rachana Kshatriya, Ada A. Cachafeiro, Ryan J. S. Kerr, Julie A. E. Nelson, and Susan A. Fiscus*

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7290

Received 8 April 2008/ Returned for modification 3 June 2008/ Accepted 23 July 2008

Modified protocols of two rapid tests were compared with a less sensitive (LS) (detuned) enzyme immunoassay (EIA) for their abilities to distinguish recent human immunodeficiency virus (HIV) seroconversion from long-term infections. The results for samples from 100 HIV-positive patient that had previously been tested by the Vironostika LS EIA had a 97% concordance with the results of the Determine HIV 1/2 assay and 93% concordance with those of the OraQuick HIV 1/2 assay.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, 79 Mary Ellen Jones, Box CB 7, Chapel Hill, NC 27599-7290. Phone: (919) 966-6872. Fax: (919) 966-9873. E-mail: fiscussa{at}med.unc.edu

{triangledown} Published ahead of print on 6 August 2008.


Journal of Clinical Microbiology, October 2008, p. 3482-3483, Vol. 46, No. 10
0095-1137/08/$08.00+0     doi:10.1128/JCM.00665-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.